Edition:
India

Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

41.50PLN
23 Sep 2020
Change (% chg)

-0.85zł (-2.01%)
Prev Close
42.35zł
Open
42.00zł
Day's High
42.35zł
Day's Low
41.15zł
Volume
17,052
Avg. Vol
26,009
52-wk High
50.40zł
52-wk Low
23.05zł

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Mar '20 30.86 0.209
FY 2019 Dec '19 26.99 0.036
Sep '19 24.00 0.047
Jun '19 24.17 0.037
Mar '19 27.09 0.144
FY 2018 Dec '18 35.14 0.139
Sep '18 31.70 0.184
Jun '18 30.24 0.169
Mar '18 28.17 0.168
 
*Note: Units in Millions ofPolish Zloty
**Note: Units in Polish Zloty

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-20 3 164.23 223.90 130.80 --
Year Ending Dec-21 3 176.60 189.40 164.00 --
Earnings (per share)
Year Ending Dec-20 2 0.57 0.59 0.56 --
Year Ending Dec-21 2 0.98 1.23 0.72 --
Sales and Profit Figures in Polish Złoty (PLN);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 40.59 31.14 33.53
P/E High - Last 5 Yrs. -- 40.50 45.20
P/E Low - Last 5 Yrs. -- 23.86 24.26
Beta -- 0.91 0.90
Price to Sales (TTM) 13.07 3.99 5.69
Price to Book (MRQ) 3.70 4.97 5.07
Price to Tangible Book (MRQ) 3.73 5.74 6.50
Price to Cash Flow (TTM) 35.44 23.03 23.51
% Owned Institutions -- 0.87 1.73

Dividends

  Company industry sector
Dividend Yield 0.51 1.55 1.49
Dividend Yield - 5 Year Avg -- 1.56 1.51
Dividend 5 Year Growth Rate -- 4.28 5.14
Payout Ratio(TTM) 0.00 45.75 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -32.12 2.37 10.57
Sales (TTM) vs TTM 1 Yr. Ago -- 4.65 5.71
Sales - 5 Yr. Growth Rate -- 9.86 10.05
EPS (MRQ) vs Qtr. 1 Yr. Ago -78.37 16.29 20.17
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.10 14.97

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 20.88 2.23 2.33
Current Ratio (MRQ) 22.56 3.05 3.16
LT Debt to Equity (MRQ) 0.00 8.79 11.31
Total Debt to Equity (MRQ) 0.00 12.59 15.51
Interest Coverage (TTM) -- 41.12 36.66

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 8.65 54.55 54.39
Gross Margin - 5 Yr. Avg. -- 52.05 52.27
EBITD Margin (TTM) 41.72 -- --
EBITD - 5 Yr. Avg -- 18.46 11.96
Operating Margin (TTM) 28.55 14.38 5.41
Operating Margin - 5 Yr. Avg. -- 14.55 7.51
Pre-Tax Margin (TTM) 29.15 14.90 6.29
Pre-Tax Margin - 5 Yr. Avg. -- 14.98 8.02
Net Profit Margin (TTM) 23.71 11.09 2.52
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.24
Effective Tax Rate (TTM) 18.64 23.42 23.33
Effective Tax Rate - 5 Yr. Avg. -- 23.64 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 978,598,613 879,042,975
Net Income/Employee (TTM) -- 116,081,974 104,231,326
Receivable Turnover (TTM) 5.20 5.78 5.98
Inventory Turnover (TTM) 2.82 2.66 3.45
Asset Turnover (TTM) 0.36 0.98 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 8.54 11.90 11.45
Return on Assets - 5 Yr. Avg. -- 13.16 12.56
Return on Investment (TTM) 8.97 15.42 14.93
Return on Investment - 5 Yr. Avg. -- 17.10 16.29
Return on Equity (TTM) 10.50 16.77 16.49
Return on Equity - 5 Yr. Avg. -- 18.03 17.40
  1 Year 3 Year 5 Year
Sales % 1.64 -- --
EPS (TTM) % -9.78 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Celon Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.46 -9.67 29 21
13 Week -8.49 -13.82 67 38
26 Week -12.44 -19.46 71 34
52 Week -- -- -- 13
YTD 36.68 9.74 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.89%
# of Holders: 19
Total Shares Held: 12,100,990
3 Mo. Net Change: -663,764
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.